All In Biotech

Drug Trial Radar · NCT00887380

STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)

A Randomised Comparison of Anastrozole Commenced Before and Continued During Adjuvant Radiotherapy for Breast Cancer Versus Anastrozole and Subsequent Anti-oestrogen Therapy Delayed Until After Radiotherapy.

Last checked: Nov 19, 2026Latest source record: Nov 18, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 2,023 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

2,023

Actual

Start

Sep 16, 2009

Primary completion

Dec 2024

Study completion Dec 2024

Sponsor

Lead sponsor
Trans Tasman Radiation Oncology GroupAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 24, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether starting anastrozole prior to radiotherapy, so that it is taken during radiotherapy, decreases local recurrence of breast cancer in post-menopausal women in comparison to waiting until after radiotherapy to commence anastrozole.

Conditions

  • Breast Cancer

Interventions

  • Pre-radiotherapy commencement of anastrozoleDrug

    Anastrozole: 1mg per day will be prescribed for 12 weeks. Commencing within 1 week of randomisation, to be administered from a min of 1 week before and a max of 4 weeks before commencement of radiotherapy and continued throughout radiotherapy. After 12 weeks administration of anastrozole according to trial regimen, anastrozole can be continued at the treating clinician's discretion and in accordance with the preference selected at the time of randomisation and stratification. The alternative options to long-term anastrozole are tamoxifen or cessation of anti-oestrogen therapy.

  • RadiotherapyRadiation

    Radiotherapy must commence within 1 month of randomisation. Radiotherapy planning and treatment is as per the protocol.

  • Post radiotherapy commencement of anastrozoleDrug

    Anastrozole 1mg per day will be prescribed for 12 weeks after radiotherapy is completed. Anastrozole should commence within 1 week of the last fraction of radiotherapy and be continued for a total of 12 weeks. After 12 weeks administration according to the trial regimen, any subsequent hormone therapy is as for the concurrent arm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To determine if commencement of anastrozole prior to radiotherapy results in improved local control compared to anastrozole commenced after radiotherapy.Time frame: 10 years post radiotherapy

Locations

34 sites in 2 countries. Site status is shown where the registry gives one.

  • The Canberra Hospital

    Canberra, Australian Capital Territory, Australia

  • Campbelltown Hospital

    Campbelltown, New South Wales, Australia

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, Australia

  • Genesis Cancer Care Hurstville

    Hurstville, New South Wales, Australia

  • St George Hospital

    Kogarah, New South Wales, Australia

  • Liverpool Hospital

    Liverpool, New South Wales, Australia

  • Calvary Mater Newcastle

    Newcastle, New South Wales, Australia

  • Central West Cancer Service

    Orange, New South Wales, Australia

  • Prince of Wales Hospital

    Randwick, New South Wales, Australia

  • Royal North Shore Hospital

    St Leonards, New South Wales, Australia

  • Riverina Cancer Centre

    Wagga Wagga, New South Wales, Australia

  • Illawarra Cancer Care Centre

    Wollongong, New South Wales, Australia

  • Alan Walker Cancer Centre

    Darwin, Northern Territory, Australia

  • Genesis Cancer Care

    Auchenflower, Queensland, Australia

  • Cairns ROQ

    Cairns, Queensland, Australia

  • Genesis Cancer Care

    Chermside, Queensland, Australia

  • The Townsville Hospital

    Douglas, Queensland, Australia

  • Radiation Oncology Gold Coast

    Gold Coast, Queensland, Australia

  • Royal Brisbane and Women's Hospital

    Herston, Queensland, Australia

  • Radiation Oncology - Mater Centre

    South Brisbane, Queensland, Australia

  • Genesis Southport

    Southport, Queensland, Australia

  • St Andrew's Toowoomba Hospital

    Toowoomba, Queensland, Australia

  • Genesis Care

    Tugun, Queensland, Australia

  • Princess Alexandra Hospital

    Woolloongabba, Queensland, Australia

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia

  • Royal Hobart Hospital

    Hobart, Tasmania, Australia

  • Geelong Hospital

    Geelong, Victoria, Australia

  • Genesis Cancer Care

    Bunbury, Western Australia, Australia

  • Fiona Stanley Hospital

    Murdoch, Western Australia, Australia

  • Royal Perth Hospital

    Perth, Western Australia, Australia

  • Perth Radiation Oncology

    Wembley, Western Australia, Australia

  • Auckland Hospital

    Auckland, New Zealand

  • Christchurch Hopsital Oncology Sevice

    Christchurch, New Zealand

  • Palmerston North

    Palmerston North, New Zealand

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.